AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $902,000 | -56.3% | 25,000 | -25.4% | 0.90% | -42.2% |
| Q3 2018 | $2,062,000 | -12.8% | 33,500 | -4.3% | 1.55% | -13.3% |
| Q2 2018 | $2,364,000 | +47.2% | 35,000 | +18.2% | 1.79% | +40.8% |
| Q1 2018 | $1,606,000 | -9.2% | 29,600 | 0.0% | 1.27% | -8.0% |
| Q4 2017 | $1,769,000 | +23.8% | 29,600 | +0.7% | 1.38% | +24.3% |
| Q3 2017 | $1,429,000 | +103.0% | 29,400 | +119.4% | 1.11% | +99.6% |
| Q2 2017 | $704,000 | -68.5% | 13,400 | -72.8% | 0.56% | -68.5% |
| Q1 2017 | $2,237,000 | -3.3% | 49,325 | -19.3% | 1.77% | -7.9% |
| Q4 2016 | $2,314,000 | -3.0% | 61,125 | -3.3% | 1.92% | +6.6% |
| Q3 2016 | $2,385,000 | +147.7% | 63,200 | +15.5% | 1.80% | +129.3% |
| Q2 2016 | $963,000 | +56.8% | 54,700 | +8.3% | 0.78% | +45.6% |
| Q1 2016 | $614,000 | -54.8% | 50,500 | -9.5% | 0.54% | -53.1% |
| Q4 2015 | $1,359,000 | +36.0% | 55,800 | -0.9% | 1.15% | +41.1% |
| Q3 2015 | $999,000 | +2.1% | 56,300 | +1.6% | 0.82% | +18.6% |
| Q2 2015 | $978,000 | +76.2% | 55,400 | +213.0% | 0.69% | +88.2% |
| Q1 2015 | $555,000 | -61.1% | 17,700 | -63.8% | 0.36% | -61.9% |
| Q4 2014 | $1,427,000 | -26.6% | 48,900 | -48.0% | 0.96% | +41.9% |
| Q3 2014 | $1,944,000 | – | 94,000 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|